Consolidated Balance Sheet

Mochida Pharmaceutical Co.,Ltd. - Filing #7353503

Concept As at
2023-12-31
As at
2023-03-31
Consolidated balance sheet
Balance sheet
Assets
Non-current assets
44,302,000,000 JPY
41,452,000,000 JPY
Investments and other assets
27,741,000,000 JPY
25,605,000,000 JPY
Investment securities
17,585,000,000 JPY
14,246,000,000 JPY
Deferred tax assets
2,861,000,000 JPY
3,883,000,000 JPY
Other
7,293,000,000 JPY
7,476,000,000 JPY
Current assets
Cash and deposits
29,909,000,000 JPY
47,010,000,000 JPY
Securities
13,499,000,000 JPY
13,499,000,000 JPY
Accounts receivable - trade
35,093,000,000 JPY
27,806,000,000 JPY
Merchandise and finished goods
17,795,000,000 JPY
14,644,000,000 JPY
Work in process
2,016,000,000 JPY
1,453,000,000 JPY
Raw materials and supplies
9,971,000,000 JPY
8,307,000,000 JPY
Other
5,235,000,000 JPY
4,656,000,000 JPY
Current assets
113,522,000,000 JPY
117,379,000,000 JPY
Non-current assets
Property, plant and equipment
Buildings and structures
Buildings and structures, net
6,904,000,000 JPY
7,069,000,000 JPY
Own-used assets
Machinery, equipment and vehicles
Machinery, equipment and vehicles, net
1,791,000,000 JPY
1,854,000,000 JPY
Land
5,993,000,000 JPY
4,990,000,000 JPY
Other
Other, net
1,142,000,000 JPY
1,135,000,000 JPY
Property, plant and equipment
15,832,000,000 JPY
15,049,000,000 JPY
Intangible assets
Intangible assets
729,000,000 JPY
797,000,000 JPY
Investments and other assets
Assets
157,825,000,000 JPY
158,831,000,000 JPY
Liabilities and net assets
Non-current liabilities
4,799,000,000 JPY
4,798,000,000 JPY
Retirement benefit liability
4,117,000,000 JPY
4,133,000,000 JPY
Current liabilities
25,846,000,000 JPY
27,258,000,000 JPY
Notes and accounts payable - trade
11,139,000,000 JPY
9,047,000,000 JPY
Liabilities
30,645,000,000 JPY
32,056,000,000 JPY
Shareholders' equity
119,242,000,000 JPY
120,930,000,000 JPY
Share capital
7,229,000,000 JPY
7,229,000,000 JPY
Capital surplus
1,871,000,000 JPY
1,871,000,000 JPY
Retained earnings
120,501,000,000 JPY
118,943,000,000 JPY
Treasury shares
-10,360,000,000 JPY
-7,114,000,000 JPY
Valuation and translation adjustments
7,937,000,000 JPY
5,844,000,000 JPY
Valuation difference on available-for-sale securities
7,781,000,000 JPY
5,655,000,000 JPY
Net assets
127,179,000,000 JPY
126,775,000,000 JPY
Liabilities and net assets
157,825,000,000 JPY
158,831,000,000 JPY
Liabilities
Non-current liabilities
Other
681,000,000 JPY
664,000,000 JPY
Current liabilities
Income taxes payable
626,000,000 JPY
501,000,000 JPY
Provisions
Provision for bonuses
1,183,000,000 JPY
2,313,000,000 JPY
Other
11,360,000,000 JPY
14,316,000,000 JPY
Net assets
Shareholders' equity
Valuation and translation adjustments
Remeasurements of defined benefit plans
155,000,000 JPY
189,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.